Showing results (691-700 of 1,826) with videos related to

Sort By:
Pageof 183
Signal Transduction and Targeted Therapy|December 5, 2024
New insights into protein-protein interaction modulators in drug discovery and therapeutic advanceHossam Nada, Yongseok Choi, Sungdo Kim, et al.
Signal Transduction and Targeted Therapy|December 5, 2024
Neutrophil diversity and function in health and diseaseFengyuan Zhang, Yidan Xia, Jiayang Su, et al.
Signal Transduction and Targeted Therapy|December 1, 2024
Liquid biopsy in cancer current: status, challenges and future prospectsLiwei Ma, Huiling Guo, Yunxiang Zhao, et al.
Signal Transduction and Targeted Therapy|December 1, 2024
BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signalingShunkang Wu, Yuelin Deng, Haobo Sun, et al.
Signal Transduction and Targeted Therapy|December 1, 2024
Phosphorylation determines the glucose metabolism reprogramming and tumor-promoting activity of sine oculis homeobox 1Yanni Lin, Ling Li, Bin Yuan, et al.
Signal Transduction and Targeted Therapy|March 19, 2025
Photodynamic gel-bombs enhance tumor penetration and downstream synergistic therapiesXiaole Bai, Fanliang Meng, Xuejiao Wang, et al.
Signal Transduction and Targeted Therapy|March 21, 2025
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugsNiklas Gremke, Isabelle Besong, Alina Stroh, et al.
Signal Transduction and Targeted Therapy|March 10, 2025
Epstein-Barr virus hijacks histone demethylase machinery to drive epithelial malignancy progression through KDM5B upregulationYa-Qing Zhou, Jia-Xin Jiang, Shuai He, et al.
Signal Transduction and Targeted Therapy|March 6, 2025
Host FSTL1 defines the impact of stem cell therapy on liver fibrosis by potentiating the early recruitment of inflammatory macrophagesXiaohong Zheng, Siyuan Tian, Ting Li, et al.
Signal Transduction and Targeted Therapy|October 28, 2024
Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)Hongtao Duan, Changjian Shao, Zhilin Luo, et al.
Pageof 183